Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.65
0.00 (0.00%)
Aug 17, 2026, 10:58 AM CST

Sofiva Genomics Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
379.21385.71453.31466.8495.78508.42
Revenue Growth
-6.67%-14.91%-2.89%-5.85%-2.49%4.00%
Gross Profit
100.7199.13135.66129.91148.99176.81
Operating Income
-18.62-33.74-3.37-15.883.7935.24
Net Income
14.23-9.3618.4311.5342.7856.98
Earnings Per Share
0.66-0.430.850.542.002.68
EPS Growth
--57.52%-73.02%-25.30%65.26%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Taiwan
368.68434.43452.32482.48496.37
Other
17.0318.8814.4813.2912.05
Total
385.71453.31466.8495.78508.42

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
131.52124.71146.18140.03170.96245.19
Total Debt
38.335.5353.3863.5974.6785.94
Net Cash (Debt)
93.2289.1892.876.4596.29159.26
Net Cash Growth
33.87%-3.90%21.39%-20.61%-39.54%35.02%
Net Cash Per Share
4.304.134.293.584.507.48

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
30.3815.3634.6923.717.1480.07
Capital Expenditures
-2.24-1.16-16.92-21.01-33.53-8.16
Free Cash Flow
28.1514.217.772.69-16.471.91
Free Cash Flow Growth
36.66%-20.11%560.18%--58.55%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
26.56%25.70%29.93%27.83%30.05%34.78%
Operating Margin
-4.91%-8.75%-0.74%-3.40%0.76%6.93%
Pretax Margin
4.87%-2.15%5.21%1.91%9.55%12.53%
Profit Margin
3.75%-2.43%4.07%2.47%8.63%11.21%
FCF Margin
7.42%3.68%3.92%0.58%-3.31%14.14%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.300-0.3000.2001.0002.000
Dividend Per Share Growth
50.77%-50.00%-80.00%-50.00%42.86%
Dividend Yield
0.89%-0.76%0.49%2.83%4.43%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
51.29-46.8175.9818.3318.29
Forward PE
-12.1912.1912.1912.0918.13
P/FCF Ratio
25.8145.8548.54325.36-14.49
PS Ratio
1.921.691.901.881.582.05